{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-25-000537","form_type":"8-K","ticker":"ZSQR","cik":"0001759186","company_name":"Z Squared Inc.","filed_at":"2025-01-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.752859+00:00","generated_at":"2026-05-27T11:21:31.825969+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Coeptis raises $1.1M convertible note and completes $10M Series A preferred stock sale","bullets":["$1.1M convertible note to Yorkville with 8% interest, maturity Dec 31, 2025; conversion price with floor at $1.00.","Series A preferred stock sale raises ~$10M from accredited investors at $1,000 per share.","Preferred investors receive 13.91% non-voting equity in subsidiaries SNAP Biosciences and GEAR Therapeutics.","Board member Christopher Calise participated in the Series A offering.","Note includes amortization events triggering monthly payments of $250k principal plus 5% premium."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-25-000537","json":"https://secwatch.observer/filing/0001683168-25-000537.json","markdown":"https://secwatch.observer/filing/0001683168-25-000537.md","text":"https://secwatch.observer/filing/0001683168-25-000537.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1759186/000168316825000537/0001683168-25-000537-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1759186/000168316825000537/coeptis_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T11:21:31.825969+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}